DRAIC and prostate carcinoma: In addition, in prostate cancer, lncRNA DRAIC can bind to IKK and reduce its kinase activity on IkB, which inhibits the activation of NF-κB, thereby inhibiting the proliferation and metastasis of prostate cancer cells (8).